» Articles » PMID: 35498391

How Advancing Are Mesoporous Silica Nanoparticles? A Comprehensive Review of the Literature

Overview
Publisher Dove Medical Press
Specialty Biotechnology
Date 2022 May 2
PMID 35498391
Authors
Affiliations
Soon will be listed here.
Abstract

The application of mesoporous silica nanoparticles (MSNs) is ubiquitous in various sciences. MSNs possess unique features, including the diversity in manufacturing by different synthesis methods and from different sources, structure controllability, pore design capabilities, pore size tunability, nanoparticle size distribution adjustment, and the ability to create diverse functional groups on their surface. These characteristics have led to various types of MSNs as a unique system for drug delivery. In this review, first, the synthesis of MSNs by different methods via using different sources were studied. Then, the parameters affecting their physicochemical properties and functionalization have been discussed. Finally, the last decade's novel strategies, including surface functionalization, drug delivery, and cancer treatment, based on the MSNs in drug delivery and cancer therapy have been addressed.

Citing Articles

A targeted and synergetic nano-delivery system against infection for promoting wound healing.

Ni C, Li X, Jiang H, Gui S, Yin H, Nie X Mater Today Bio. 2025; 31:101470.

PMID: 39882550 PMC: 11772151. DOI: 10.1016/j.mtbio.2025.101470.


Nano Delivery System for Atherosclerosis.

Rong Z, He X, Fan T, Zhang H J Funct Biomater. 2025; 16(1).

PMID: 39852558 PMC: 11766408. DOI: 10.3390/jfb16010002.


A Review of Current Developments in Functionalized Mesoporous Silica Nanoparticles: From Synthesis to Biosensing Applications.

Zhou J, Liu C, Zhong Y, Luo Z, Wu L Biosensors (Basel). 2024; 14(12.

PMID: 39727840 PMC: 11727617. DOI: 10.3390/bios14120575.


Mapping global research landscape and trend of nano-drug delivery system for urological cancers: a bibliometric analysis.

Shi Y, Fu Z, Yu X, Zhang Y, Fan G, Wang Z Nanomedicine (Lond). 2024; 19(26):2139-2157.

PMID: 39225560 PMC: 11485865. DOI: 10.1080/17435889.2024.2391267.


Strategies to Regulate the Degradation and Clearance of Mesoporous Silica Nanoparticles: A Review.

Zhang Y, Lin X, Chen X, Fang W, Yu K, Gu W Int J Nanomedicine. 2024; 19:5859-5878.

PMID: 38887691 PMC: 11182361. DOI: 10.2147/IJN.S451919.


References
1.
Shen S, Tang H, Zhang X, Ren J, Pang Z, Wang D . Targeting mesoporous silica-encapsulated gold nanorods for chemo-photothermal therapy with near-infrared radiation. Biomaterials. 2013; 34(12):3150-8. DOI: 10.1016/j.biomaterials.2013.01.051. View

2.
Cheraghian G, Wistuba M . Effect of Fumed Silica Nanoparticles on Ultraviolet Aging Resistance of Bitumen. Nanomaterials (Basel). 2021; 11(2). PMC: 7916902. DOI: 10.3390/nano11020454. View

3.
Yao P, Zou A, Tian Z, Meng W, Fang X, Wu T . Construction and characterization of a temperature-responsive nanocarrier for imidacloprid based on mesoporous silica nanoparticles. Colloids Surf B Biointerfaces. 2020; 198:111464. DOI: 10.1016/j.colsurfb.2020.111464. View

4.
Kundu M, Sadhukhan P, Ghosh N, Ghosh S, Chatterjee S, Das J . In vivo therapeutic evaluation of a novel bis-lawsone derivative against tumor following delivery using mesoporous silica nanoparticle based redox-responsive drug delivery system. Mater Sci Eng C Mater Biol Appl. 2021; 126:112142. DOI: 10.1016/j.msec.2021.112142. View

5.
Wang Y, Han N, Zhao Q, Bai L, Li J, Jiang T . Redox-responsive mesoporous silica as carriers for controlled drug delivery: a comparative study based on silica and PEG gatekeepers. Eur J Pharm Sci. 2015; 72:12-20. DOI: 10.1016/j.ejps.2015.02.008. View